An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
Stopped early
Conditions studied: Hepatitis B, Hepatitis, Liver Diseases
In brief
The TARGET-HBV study engages an observational research design to conduct a comprehensive review of outcomes for patients with CHB infection. The initial phase of the study that enrolled patients treated with tenofovir alafenamide (TAF) was successfully completed. The current protocol (Amendment 1) describes the second phase of the study that will engage research activities for patients being managed for CHB in usual clinical practice in the US and Canada. The study addresses important clinical questions regarding the management of CHB by collecting and analyzing data from patients at academic and community medical centers. TARGET-HBV creates a robust database of real-world data regarding the natural history, management, and health outcomes related to antiviral treatments used in clinical practice.
Key facts
- Study ID
- NCT03692897
- Run by
- Target PharmaSolutions, Inc.
- People needed
- 1708
- Starts
- 2018-10-11
- Expected to finish
- 2025-09-10
- Last updated by the study team
- 2025-09-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Banner University Medical Center Phoenix — Phoenix, Arizona, United States
- Asian Pacific Liver Center at Coalition of Inclusive Medicine — Los Angeles, California, United States
- California Liver Research Institute — Pasadena, California, United States
- Stanford University — Redwood City, California, United States
- UC Davis GI/Hepatology Clinical Trials Unit — Sacramento, California, United States
- Silicon Valley Research Institute — San Jose, California, United States
- Yale University Digestive Diseases — New Haven, Connecticut, United States
- Medstar Georgetown University Hospital — Washington D.C., District of Columbia, United States
- University of Florida — Gainesville, Florida, United States
- University of Miami, Schiff Center for Liver Disease — Miami, Florida, United States
- Consultative Gastroenterology — Atlanta, Georgia, United States
- Atlanta Gastroenterology — Atlanta, Georgia, United States
- Rush Universtiy Medical Center — Chicago, Illinois, United States
- University of Chicago — Chicago, Illinois, United States
- Mercy Medical Center — Baltimore, Maryland, United States
- University of Michigan — Ann Arbor, Michigan, United States
- Minnesota Gastroenterology, P.A. — Plymouth, Minnesota, United States
- Rutgers, Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States
- Dreamwork Medical, PLLC — Flushing, New York, United States
- Northwell Health Center for Liver Diseases and Transplantation — Manhasset, New York, United States
- NYU Langone Health — New York, New York, United States
- Weill Cornell Medical College — New York, New York, United States
- Columbia University Medical Center — New York, New York, United States
- UNC Liver Center — Chapel Hill, North Carolina, United States
- UT Southwestern Medical Center — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.